Enhancing Capital’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.21M Hold
22,067
– – 2.22% 16
2026
Q2
$2.84M Hold
22,067
– – 1.95% 18
2026
Q1
$2.65M Hold
22,067
– – 1.97% 16
2025
Q4
$2.32M Hold
22,067
– – 1.66% 18
2025
Q3
$1.85M Hold
22,067
– – 1.36% 22
2025
Q2
$1.75M Hold
22,067
– – 1.33% 23
2025
Q1
$1.98M Hold
22,067
– – 1.58% 21
2024
Q4
$2.2M Buy
+22,067
New +$2.27M 1.75% 18
2022
Q3
$1.94M Hold
22,182
– – 2.4% 12
2022
Q2
$2.02M Hold
22,182
– – 2.41% 13
2022
Q1
$1.82M Hold
22,182
– – 1.95% 17
2021
Q4
$1.7M Buy
+22,182
New +$1.77M 1.85% 17

Other funds holding MRK

Enhancing Capital's MRK Position: Q3 2026 in Review

Enhancing Capital held its Merck (MRK) position steady in Q3 2026 at 22,067 shares worth $3.21M. The position accounts for 2.22% of the portfolio, ranked #16.

Enhancing Capital first reported a position in MRK in Q4 2021 and has held it in 12 quarters since. 1,705 funds tracked by Wall St. Rank hold MRK as of Q3 2026.

  • Enhancing Capital held 22,067 shares of Merck worth $3.21M as of Q3 2026.
  • Enhancing Capital left its Merck share count unchanged in Q3 2026.
  • Merck made up 2.22% of Enhancing Capital's portfolio in Q3 2026, its #16 holding.
  • Enhancing Capital first reported a position in Merck in Q4 2021 and has held it in 12 quarters since.
  • 1,705 funds tracked by Wall St. Rank held Merck as of Q3 2026.

Based on Enhancing Capital's 13F filing for Q3 2026, filed 26 Oct 2026.